In today’s recent session, 0.42 million shares of the Amarin Corp ADR (NASDAQ:AMRN) have been traded, and its beta is 1.83. Most recently the company’s share price was $0.52, and it changed around -$0.02 or -3.64% from the last close, which brings the market valuation of the company to $214.39M. AMRN at last check was trading at a discount to its 52-week high of $1.36, offering almost -161.54% off that amount. The share price’s 52-week low was $0.43, which indicates that the recent value has risen by an impressive 17.31% since then. We note from Amarin Corp ADR’s average daily trading volume that its 10-day average is 0.97 million shares, with the 3-month average coming to 1.54 million.
Amarin Corp ADR stock received a consensus recommendation rating of Underweight, based on a mean score of 4.33. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended AMRN as a Hold, whereas 0 deemed it a Buy, and 2 rated it as Underweight. Amarin Corp ADR is expected to report earnings per share of -0.03 for the current quarter.
Amarin Corp ADR (NASDAQ:AMRN) trade information
Instantly AMRN has been showing red trend so far today with a performance of -3.64% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.6007 on recent trading dayincreased the stock’s daily price by 13.43%. The company’s shares are currently up 7.48% year-to-date, but still down -5.94% over the last five days. On the other hand, Amarin Corp ADR (NASDAQ:AMRN) is -5.78% down in the 30-day period. We can see from the shorts that 17.19 million shares have been sold at a short interest cover period of 9.32 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 74.0% from its current value. Analyst projections state that AMRN is forecast to be at a low of $1.5 and a high of $3.
Amarin Corp ADR (AMRN) estimates and forecasts
The year-over-year growth rate is expected to be -34.25%, down from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 31.69M in revenue for the current quarter. 1 analysts expect Amarin Corp ADR to make 36.86M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 74.71M and 56.52M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -57.58%. Forecasts for the next quarter put sales growth at -34.78%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.93%. Amarin Corp ADR earnings are expected to increase by 6.37% in 2025, but the outlook is positive 8.15% per year for the next five years.
AMRN Dividends
Amarin Corp ADR’s next quarterly earnings report is expected to be released in March.
Amarin Corp ADR (NASDAQ:AMRN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.82% of Amarin Corp ADR shares, and 17.34% of them are in the hands of institutional investors. The stock currently has a share float of 17.66%. Amarin Corp ADR stock is held by 193.0 institutions, with SARISSA CAPITAL MANAGEMENT LP being the largest institutional investor. By 2024-06-30, it held 6.059% of the shares, which is about 24.85 million shares worth $17.1 million.
KYNAM CAPITAL MANAGEMENT, LP, with 2.9638% or 12.16 million shares worth $8.36 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
SPDR Portfolio Developed World ex-US ETF and Delaware Group Equity Fds IV-Delaware Healthcare Fund were the top two Mutual Funds as of Nov 30, 2024. The former held 252.28 shares worth $0.13 million, making up 0.26% of all outstanding shares. On the other hand, Delaware Group Equity Fds IV-Delaware Healthcare Fund held roughly 190.0 shares worth around $99008.0, which represents about 0.19% of the total shares outstanding.
